Concentrix Financials
This page shows Concentrix (CNXC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
Concentrix has an operating margin of -9.3%, meaning the company retains $-9 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from 6.2% the prior year.
Concentrix's revenue grew a modest 2.2% year-over-year to $9.8B. This slow but positive growth earns a score of 35/100.
Concentrix has a moderate D/E ratio of 1.67. This balance of debt and equity financing earns a leverage score of 49/100.
Concentrix's current ratio of 1.40 indicates adequate short-term liquidity, earning a score of 36/100. The company can meet its near-term obligations, though with limited headroom.
Concentrix's free cash flow margin of 5.8% results in a low score of 29/100. Capital expenditures of $234.5M absorb a large share of operating cash flow.
Concentrix passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Concentrix generates $-0.63 in operating cash flow ($807.0M OCF vs -$1.3B net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Concentrix earns $-3.2 in operating income for every $1 of interest expense (-$918.2M vs $290.3M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Concentrix generated $9.8B in revenue in fiscal year 2025. This represents an increase of 2.2% from the prior year.
Concentrix's EBITDA was -$257.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 119.8% from the prior year.
Concentrix generated $572.5M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 33.5% from the prior year.
Concentrix reported -$1.3B in net income in fiscal year 2025. This represents a decrease of 609.1% from the prior year.
Concentrix earned $-20.36 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 648.8% from the prior year.
Concentrix held $327.3M in cash against $4.6B in long-term debt as of fiscal year 2025.
Concentrix had 62M shares outstanding in fiscal year 2025. This represents a decrease of 4.3% from the prior year.
Concentrix's gross margin was 35.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.9 percentage points from the prior year.
Concentrix's operating margin was -9.3% in fiscal year 2025, reflecting core business profitability. This is down 15.5 percentage points from the prior year.
Concentrix's net profit margin was -13.0% in fiscal year 2025, showing the share of revenue converted to profit. This is down 15.6 percentage points from the prior year.
Concentrix spent $168.7M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 24.0% from the prior year.
Concentrix invested $234.5M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 1.8% from the prior year.
CNXC Income Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.6B+2.8% | $2.5B+2.7% | $2.4B+1.9% | $2.4B-3.1% | $2.4B+2.5% | $2.4B+0.3% | $2.4B-0.9% | $2.4B |
| Cost of Revenue | $1.7B+3.0% | $1.6B+3.8% | $1.6B+3.5% | $1.5B-3.9% | $1.6B+3.6% | $1.5B0.0% | $1.5B-1.5% | $1.5B |
| Gross Profit | $876.0M+2.5% | $855.0M+0.8% | $848.1M-0.9% | $855.9M-1.7% | $870.6M+0.7% | $864.2M+0.8% | $857.6M+0.1% | $856.5M |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $730.6M+3.2% | $708.0M+1.2% | $699.8M+1.9% | $687.0M-5.4% | $726.1M+2.1% | $711.0M+0.5% | $707.4M-0.1% | $708.1M |
| Operating Income | -$1.4B-1040.5% | $147.0M-0.9% | $148.3M-12.2% | $168.9M+16.8% | $144.5M-5.7% | $153.2M+2.0% | $150.2M+1.2% | $148.4M |
| Interest Expense | $69.9M-2.9% | $72.0M-4.5% | $75.4M+3.3% | $73.0M-4.1% | $76.1M-5.8% | $80.8M-2.0% | $82.5M0.0% | $82.4M |
| Income Tax | $33.2M+42.3% | $23.3M+142.4% | $9.6M-68.5% | $30.5M+1212.8% | -$2.7M-128.0% | $9.8M-51.8% | $20.3M-2.1% | $20.7M |
| Net Income | -$1.5B-1779.0% | $88.1M+109.3% | $42.1M-40.1% | $70.3M-39.3% | $115.7M+595.4% | $16.6M-75.1% | $66.8M+28.3% | $52.1M |
| EPS (Diluted) | $-23.37-1844.0% | $1.34+112.7% | $0.63-39.4% | $1.04-39.5% | $1.72+588.0% | $0.25-74.5% | $0.98+28.9% | $0.76 |
CNXC Balance Sheet
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $10.8B-13.3% | $12.4B+0.1% | $12.4B+4.2% | $11.9B-0.8% | $12.0B-1.8% | $12.2B+1.1% | $12.1B-1.3% | $12.2B |
| Current Assets | $3.1B-1.7% | $3.1B-1.0% | $3.2B+7.1% | $3.0B+4.2% | $2.8B-0.3% | $2.9B+4.9% | $2.7B-2.4% | $2.8B |
| Cash & Equivalents | $327.3M-6.5% | $350.3M+2.2% | $342.8M+11.3% | $308.0M+28.0% | $240.6M-2.3% | $246.2M+18.8% | $207.3M-11.7% | $234.8M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $2.0B-2.6% | $2.1B-0.5% | $2.1B+2.3% | $2.0B+4.6% | $1.9B-0.5% | $1.9B+3.4% | $1.9B-2.9% | $1.9B |
| Goodwill | $3.7B-29.3% | $5.2B+1.2% | $5.1B+4.0% | $4.9B-1.0% | $5.0B-1.9% | $5.1B+1.2% | $5.0B-0.1% | $5.0B |
| Total Liabilities | $8.0B-0.6% | $8.1B-0.6% | $8.1B+3.3% | $7.9B-1.1% | $8.0B-1.1% | $8.0B+0.5% | $8.0B-1.8% | $8.1B |
| Current Liabilities | $2.2B+9.3% | $2.0B+1.8% | $2.0B+10.1% | $1.8B-10.2% | $2.0B+10.1% | $1.8B+2.6% | $1.8B-0.9% | $1.8B |
| Long-Term Debt | $4.6B-4.5% | $4.8B-1.5% | $4.9B-0.8% | $4.9B+3.6% | $4.7B-3.6% | $4.9B-0.3% | $4.9B-2.2% | $5.0B |
| Total Equity | $2.7B-36.8% | $4.3B+1.5% | $4.3B+6.1% | $4.0B-0.1% | $4.0B-3.1% | $4.2B+2.1% | $4.1B-0.4% | $4.1B |
| Retained Earnings | -$177.0M-113.4% | $1.3B+5.3% | $1.3B+1.6% | $1.2B+4.0% | $1.2B+8.5% | $1.1B-0.3% | $1.1B+4.4% | $1.1B |
CNXC Cash Flow Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $344.2M+53.1% | $224.8M-5.0% | $236.5M+16699.4% | $1.4M-99.5% | $284.4M+48.4% | $191.6M-19.6% | $238.3M+608.5% | -$46.9M |
| Capital Expenditures | $63.0M-3.1% | $65.1M+16.6% | $55.8M+10.2% | $50.6M-15.5% | $59.9M-4.6% | $62.7M+4.4% | $60.1M+7.2% | $56.1M |
| Free Cash Flow | $281.2M+76.0% | $159.7M-11.6% | $180.7M+467.3% | -$49.2M-121.9% | $224.5M+74.2% | $128.9M-27.7% | $178.3M+273.2% | -$102.9M |
| Investing Cash Flow | -$78.3M-20.3% | -$65.1M-16.6% | -$55.8M-8.8% | -$51.3M+15.8% | -$60.9M+3.0% | -$62.7M-4.4% | -$60.1M+0.8% | -$60.6M |
| Financing Cash Flow | -$280.0M-69.9% | -$164.8M-10.7% | -$148.9M-245.6% | $102.3M+145.6% | -$224.5M-164.7% | -$84.8M+57.1% | -$197.7M-1468.9% | $14.4M |
| Dividends Paid | $23.2M+5.7% | $22.0M-0.9% | $22.2M-1.0% | $22.4M-1.1% | $22.6M+12.0% | $20.2M-0.6% | $20.3M-1.3% | $20.6M |
| Share Buybacks | $55.9M+34.5% | $41.6M-8.2% | $45.3M+75.4% | $25.8M-25.0% | $34.5M-12.3% | $39.3M-3.3% | $40.6M+87.5% | $21.7M |
CNXC Financial Ratios
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 34.3%-0.1pp | 34.4%-0.7pp | 35.1%-1.0pp | 36.1%+0.5pp | 35.6%-0.6pp | 36.2%+0.2pp | 36.0%+0.4pp | 35.6% |
| Operating Margin | -54.1%-60.1pp | 5.9%-0.2pp | 6.1%-1.0pp | 7.1%+1.2pp | 5.9%-0.5pp | 6.4%+0.1pp | 6.3%+0.1pp | 6.2% |
| Net Margin | -58.0%-61.5pp | 3.5%+1.8pp | 1.7%-1.2pp | 3.0%-1.8pp | 4.7%+4.0pp | 0.7%-2.1pp | 2.8%+0.6pp | 2.2% |
| Return on Equity | N/A | 2.0%+1.0pp | 1.0%-0.8pp | 1.7%-1.1pp | 2.9%+2.5pp | 0.4%-1.2pp | 1.6%+0.4pp | 1.3% |
| Return on Assets | -13.8%-14.5pp | 0.7%+0.4pp | 0.3%-0.3pp | 0.6%-0.4pp | 1.0%+0.8pp | 0.1%-0.4pp | 0.5%+0.1pp | 0.4% |
| Current Ratio | 1.40-0.2 | 1.56-0.0 | 1.61-0.0 | 1.65+0.2 | 1.42-0.1 | 1.57+0.0 | 1.54-0.0 | 1.56 |
| Debt-to-Equity | 1.67+0.6 | 1.10-0.0 | 1.14-0.1 | 1.22+0.0 | 1.170.0 | 1.18-0.0 | 1.21-0.0 | 1.23 |
| FCF Margin | 11.0%+4.6pp | 6.4%-1.1pp | 7.5%+9.6pp | -2.1%-11.2pp | 9.2%+3.8pp | 5.4%-2.1pp | 7.5%+11.8pp | -4.3% |
Similar Companies
Frequently Asked Questions
What is Concentrix's annual revenue?
Concentrix (CNXC) reported $9.8B in total revenue for fiscal year 2025. This represents a 2.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Concentrix's revenue growing?
Concentrix (CNXC) revenue grew by 2.2% year-over-year, from $9.6B to $9.8B in fiscal year 2025.
Is Concentrix profitable?
No, Concentrix (CNXC) reported a net income of -$1.3B in fiscal year 2025, with a net profit margin of -13.0%.
What is Concentrix's earnings per share (EPS)?
Concentrix (CNXC) reported diluted earnings per share of $-20.36 for fiscal year 2025. This represents a -648.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Concentrix's EBITDA?
Concentrix (CNXC) had EBITDA of -$257.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Concentrix have?
As of fiscal year 2025, Concentrix (CNXC) had $327.3M in cash and equivalents against $4.6B in long-term debt.
What is Concentrix's gross margin?
Concentrix (CNXC) had a gross margin of 35.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Concentrix's operating margin?
Concentrix (CNXC) had an operating margin of -9.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Concentrix's net profit margin?
Concentrix (CNXC) had a net profit margin of -13.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Concentrix's free cash flow?
Concentrix (CNXC) generated $572.5M in free cash flow during fiscal year 2025. This represents a 33.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Concentrix's operating cash flow?
Concentrix (CNXC) generated $807.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Concentrix's total assets?
Concentrix (CNXC) had $10.8B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Concentrix's capital expenditures?
Concentrix (CNXC) invested $234.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
Does Concentrix buy back shares?
Yes, Concentrix (CNXC) spent $168.7M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.
How many shares does Concentrix have outstanding?
Concentrix (CNXC) had 62M shares outstanding as of fiscal year 2025.
What is Concentrix's current ratio?
Concentrix (CNXC) had a current ratio of 1.40 as of fiscal year 2025, which is considered adequate.
What is Concentrix's debt-to-equity ratio?
Concentrix (CNXC) had a debt-to-equity ratio of 1.67 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Concentrix's return on assets (ROA)?
Concentrix (CNXC) had a return on assets of -11.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Concentrix's Piotroski F-Score?
Concentrix (CNXC) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Concentrix's earnings high quality?
Concentrix (CNXC) has an earnings quality ratio of -0.63x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Concentrix cover its interest payments?
Concentrix (CNXC) has an interest coverage ratio of -3.2x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Concentrix?
Concentrix (CNXC) scores 30 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.